P281424/AMR
1
0
Fork 0
mirror of https://github.com/msberends/AMR.git synced 2026-05-31 13:41:42 +02:00
Code Releases Activity

Built site for AMR@3.0.1.9053: 23beebc

Browse Source
This commit is contained in:
github-actions
2026-04-30 08:07:42 +00:00
parent 425f4ad827
commit 3a3027f171
100 changed files with 742 additions and 649 deletions
Download Patch File Download Diff File Expand all files Collapse all files

108
articles/datasets.md
View File

@@ -78,14 +78,14 @@ Included (sub)species per taxonomic kingdom:
First 6 rows when filtering on genus *Escherichia*:
| mo | fullname | status | kingdom | phylum | class | order | family | genus | species | subspecies | rank | ref | oxygen_tolerance | source | lpsn | lpsn_parent | lpsn_renamed_to | mycobank | mycobank_parent | mycobank_renamed_to | gbif | gbif_parent | gbif_renamed_to | prevalence | snomed |
|:-----------------:|:--------------------------:|:--------:|:--------:|:--------------:|:-------------------:|:----------------:|:------------------:|:-----------:|:--------------:|:----------:|:----------:|:-----------------------:|:---------------------------:|:------:|:------:|:-----------:|:---------------:|:--------:|:---------------:|:-------------------:|:--------:|:-----------:|:---------------:|:----------:|:-----------------------------------------:|
| B_ESCHR | Escherichia | accepted | Bacteria | Pseudomonadota | Gammaproteobacteria | Enterobacterales | Enterobacteriaceae | Escherichia | | | genus | Castellani et al., 1919 | facultative anaerobe | LPSN | 515602 | 482 | | | | | | 11158430 | | 1 | 407310004, 407251000, 407281008, … |
| B_ESCHR_ADCR | Escherichia adecarboxylata | synonym | Bacteria | Pseudomonadota | Gammaproteobacteria | Enterobacterales | Enterobacteriaceae | Escherichia | adecarboxylata | | species | Leclerc, 1962 | likely facultative anaerobe | LPSN | 776052 | 515602 | 777447 | | | | | | | 1 | |
| B_ESCHR_ALBR | Escherichia albertii | accepted | Bacteria | Pseudomonadota | Gammaproteobacteria | Enterobacterales | Enterobacteriaceae | Escherichia | albertii | | species | Huys et al., 2003 | facultative anaerobe | LPSN | 776053 | 515602 | | | | | 5427575 | | | 1 | 419388003 |
| B_ESCHR_BLTT | Escherichia blattae | synonym | Bacteria | Pseudomonadota | Gammaproteobacteria | Enterobacterales | Enterobacteriaceae | Escherichia | blattae | | species | Burgess et al., 1973 | likely facultative anaerobe | LPSN | 776056 | 515602 | 788468 | | | | | | | 1 | |
| B_ESCHR_COLI | Escherichia coli | accepted | Bacteria | Pseudomonadota | Gammaproteobacteria | Enterobacterales | Enterobacteriaceae | Escherichia | coli | | species | Castellani et al., 1919 | facultative anaerobe | LPSN | 776057 | 515602 | | | | | 11286021 | | | 1 | 1095001000112106, 715307006, 737528008, … |
| B_ESCHR_COLI_COLI | Escherichia coli coli | accepted | Bacteria | Pseudomonadota | Gammaproteobacteria | Enterobacterales | Enterobacteriaceae | Escherichia | coli | coli | subspecies | | | GBIF | | 776057 | | | | | 12233256 | 11286021 | | 1 | |
| mo | fullname | status | kingdom | phylum | class | order | family | genus | species | subspecies | rank | ref | oxygen_tolerance | source | lpsn | lpsn_parent | lpsn_renamed_to | mycobank | mycobank_parent | mycobank_renamed_to | gbif | gbif_parent | gbif_renamed_to | prevalence | snomed |
|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|
| B_ESCHR | Escherichia | accepted | Bacteria | Pseudomonadota | Gammaproteobacteria | Enterobacterales | Enterobacteriaceae | Escherichia | | | genus | Castellani et al., 1919 | facultative anaerobe | LPSN | 515602 | 482 | | | | | | 11158430 | | 1 | 407310004, 407251000, 407281008, … |
| B_ESCHR_ADCR | Escherichia adecarboxylata | synonym | Bacteria | Pseudomonadota | Gammaproteobacteria | Enterobacterales | Enterobacteriaceae | Escherichia | adecarboxylata | | species | Leclerc, 1962 | likely facultative anaerobe | LPSN | 776052 | 515602 | 777447 | | | | | | | 1 | |
| B_ESCHR_ALBR | Escherichia albertii | accepted | Bacteria | Pseudomonadota | Gammaproteobacteria | Enterobacterales | Enterobacteriaceae | Escherichia | albertii | | species | Huys et al., 2003 | facultative anaerobe | LPSN | 776053 | 515602 | | | | | 5427575 | | | 1 | 419388003 |
| B_ESCHR_BLTT | Escherichia blattae | synonym | Bacteria | Pseudomonadota | Gammaproteobacteria | Enterobacterales | Enterobacteriaceae | Escherichia | blattae | | species | Burgess et al., 1973 | likely facultative anaerobe | LPSN | 776056 | 515602 | 788468 | | | | | | | 1 | |
| B_ESCHR_COLI | Escherichia coli | accepted | Bacteria | Pseudomonadota | Gammaproteobacteria | Enterobacterales | Enterobacteriaceae | Escherichia | coli | | species | Castellani et al., 1919 | facultative anaerobe | LPSN | 776057 | 515602 | | | | | 11286021 | | | 1 | 1095001000112106, 715307006, 737528008, … |
| B_ESCHR_COLI_COLI | Escherichia coli coli | accepted | Bacteria | Pseudomonadota | Gammaproteobacteria | Enterobacterales | Enterobacteriaceae | Escherichia | coli | coli | subspecies | | | GBIF | | 776057 | | | | | 12233256 | 11286021 | | 1 | |
------------------------------------------------------------------------
@@ -134,14 +134,14 @@ as comma separated values.
**Example content**
| ab | cid | name | group | atc | atc_group1 | atc_group2 | abbreviations | synonyms | oral_ddd | oral_units | iv_ddd | iv_units | loinc |
|:---:|:--------:|:---------------------------:|:----------------------------------------------:|:------------------------------:|:-------------------------------------------:|:------------------------------------------------------------:|:-------------------:|:-------------------------------------------------------:|:--------:|:----------:|:------:|:--------:|:------------------------------:|
| AMK | 37768 | Amikacin | Aminoglycosides | D06AX12, J01GB06, QD06AX12, … | Aminoglycoside antibacterials | Other aminoglycosides | ak, ami, amik, … | amikacillin, amikacina, amikacine, … | | | 1.0 | g | 101493-5, 11-7, 12-5, … |
| AMX | 33613 | Amoxicillin | Aminopenicillins, Penicillins, Beta-lactams | J01CA04, QG51AA03, QJ01CA04 | Beta-lactam antibacterials, penicillins | Penicillins with extended spectrum | ac, amox, amoxic, … | acuotricina, alfamox, alfida, … | 1.5 | g | 3.0 | g | 101498-4, 15-8, 16-6, … |
| AMC | 23665637 | Amoxicillin/clavulanic acid | Aminopenicillins, Penicillins, Beta-lactams, … | J01CR02, QJ01CR02 | Beta-lactam antibacterials, penicillins | Combinations of penicillins, incl. beta-lactamase inhibitors | a/c, amcl, aml, … | amocla, amoclan, amoclav, … | 1.5 | g | 3.0 | g | |
| AMP | 6249 | Ampicillin | Aminopenicillins, Penicillins, Beta-lactams | J01CA01, QJ01CA01, QJ51CA01, … | Beta-lactam antibacterials, penicillins | Penicillins with extended spectrum | am, amp, amp100, … | adobacillin, alpen, amblosin, … | 2.0 | g | 6.0 | g | 101477-8, 101478-6, 18864-9, … |
| AZM | 447043 | Azithromycin | Macrolides | J01FA10, QJ01FA10, QS01AA26, … | Macrolides, lincosamides and streptogramins | Macrolides | az, azi, azit, … | aritromicina, aruzilina, azasite, … | 0.3 | g | 0.5 | g | 100043-9, 16420-2, 16421-0, … |
| PEN | 5904 | Benzylpenicillin | Penicillins, Beta-lactams | J01CE01, QJ01CE01, QJ51CE01, … | Combinations of antibacterials | Combinations of antibacterials | bepe, pen, peni, … | bencilpenicilina, benzopenicillin, benzylpenicilline, … | | | 3.6 | g | |
| ab | cid | name | group | atc | atc_group1 | atc_group2 | abbreviations | synonyms | oral_ddd | oral_units | iv_ddd | iv_units | loinc |
|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|
| AMK | 37768 | Amikacin | Aminoglycosides | D06AX12, J01GB06, QD06AX12, … | Aminoglycoside antibacterials | Other aminoglycosides | ak, ami, amik, … | amikacillin, amikacina, amikacine, … | | | 1.0 | g | 101493-5, 11-7, 12-5, … |
| AMX | 33613 | Amoxicillin | Aminopenicillins, Penicillins, Beta-lactams | J01CA04, QG51AA03, QJ01CA04 | Beta-lactam antibacterials, penicillins | Penicillins with extended spectrum | ac, amox, amoxic, … | acuotricina, alfamox, alfida, … | 1.5 | g | 3.0 | g | 101498-4, 15-8, 16-6, … |
| AMC | 23665637 | Amoxicillin/clavulanic acid | Aminopenicillins, Penicillins, Beta-lactams, … | J01CR02, QJ01CR02 | Beta-lactam antibacterials, penicillins | Combinations of penicillins, incl. beta-lactamase inhibitors | a/c, amcl, aml, … | amocla, amoclan, amoclav, … | 1.5 | g | 3.0 | g | |
| AMP | 6249 | Ampicillin | Aminopenicillins, Penicillins, Beta-lactams | J01CA01, QJ01CA01, QJ51CA01, … | Beta-lactam antibacterials, penicillins | Penicillins with extended spectrum | am, amp, amp100, … | adobacillin, alpen, amblosin, … | 2.0 | g | 6.0 | g | 101477-8, 101478-6, 18864-9, … |
| AZM | 447043 | Azithromycin | Macrolides | J01FA10, QJ01FA10, QS01AA26, … | Macrolides, lincosamides and streptogramins | Macrolides | az, azi, azit, … | aritromicina, aruzilina, azasite, … | 0.3 | g | 0.5 | g | 100043-9, 16420-2, 16421-0, … |
| PEN | 5904 | Benzylpenicillin | Penicillins, Beta-lactams | J01CE01, QJ01CE01, QJ51CE01, … | Combinations of antibacterials | Combinations of antibacterials | bepe, pen, peni, … | bencilpenicilina, benzopenicillin, benzylpenicilline, … | | | 3.6 | g | |
------------------------------------------------------------------------
@@ -186,14 +186,14 @@ here](https://amr-for-r.org/reference/clinical_breakpoints.html).
**Example content**
| guideline | type | host | method | site | mo | mo_name | rank_index | ab | ab_name | ref_tbl | disk_dose | breakpoint_S | breakpoint_R | uti | is_SDD |
|:-----------:|:-----:|:-----:|:------:|:----:|:-------------:|:--------------------------:|:----------:|:---:|:-----------------------------:|:---------------:|:--------------:|:------------:|:------------:|:-----:|:------:|
| EUCAST 2026 | human | human | DISK | | B_ACHRMB_XYLS | Achromobacter xylosoxidans | 2 | MEM | Meropenem | A. xylosoxidans | 10 mcg | 26.000 | 20.000 | FALSE | FALSE |
| EUCAST 2026 | human | human | MIC | | B_ACHRMB_XYLS | Achromobacter xylosoxidans | 2 | MEM | Meropenem | A. xylosoxidans | | 1.000 | 4.000 | FALSE | FALSE |
| EUCAST 2026 | human | human | DISK | | B_ACHRMB_XYLS | Achromobacter xylosoxidans | 2 | SXT | Trimethoprim/sulfamethoxazole | A. xylosoxidans | 1.25/23.75 mcg | 26.000 | 26.000 | FALSE | FALSE |
| EUCAST 2026 | human | human | MIC | | B_ACHRMB_XYLS | Achromobacter xylosoxidans | 2 | SXT | Trimethoprim/sulfamethoxazole | A. xylosoxidans | | 0.125 | 0.125 | FALSE | FALSE |
| EUCAST 2026 | human | human | DISK | | B_ACHRMB_XYLS | Achromobacter xylosoxidans | 2 | TZP | Piperacillin/tazobactam | A. xylosoxidans | 30/6 mcg | 26.000 | 26.000 | FALSE | FALSE |
| EUCAST 2026 | human | human | MIC | | B_ACHRMB_XYLS | Achromobacter xylosoxidans | 2 | TZP | Piperacillin/tazobactam | A. xylosoxidans | | 4.000 | 4.000 | FALSE | FALSE |
| guideline | type | host | method | site | mo | mo_name | rank_index | ab | ab_name | ref_tbl | disk_dose | breakpoint_S | breakpoint_R | uti | is_SDD |
|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|
| EUCAST 2026 | human | human | DISK | | B_ACHRMB_XYLS | Achromobacter xylosoxidans | 2 | MEM | Meropenem | A. xylosoxidans | 10 mcg | 26.000 | 20.000 | FALSE | FALSE |
| EUCAST 2026 | human | human | MIC | | B_ACHRMB_XYLS | Achromobacter xylosoxidans | 2 | MEM | Meropenem | A. xylosoxidans | | 1.000 | 4.000 | FALSE | FALSE |
| EUCAST 2026 | human | human | DISK | | B_ACHRMB_XYLS | Achromobacter xylosoxidans | 2 | SXT | Trimethoprim/sulfamethoxazole | A. xylosoxidans | 1.25/23.75 mcg | 26.000 | 26.000 | FALSE | FALSE |
| EUCAST 2026 | human | human | MIC | | B_ACHRMB_XYLS | Achromobacter xylosoxidans | 2 | SXT | Trimethoprim/sulfamethoxazole | A. xylosoxidans | | 0.125 | 0.125 | FALSE | FALSE |
| EUCAST 2026 | human | human | DISK | | B_ACHRMB_XYLS | Achromobacter xylosoxidans | 2 | TZP | Piperacillin/tazobactam | A. xylosoxidans | 30/6 mcg | 26.000 | 26.000 | FALSE | FALSE |
| EUCAST 2026 | human | human | MIC | | B_ACHRMB_XYLS | Achromobacter xylosoxidans | 2 | TZP | Piperacillin/tazobactam | A. xylosoxidans | | 4.000 | 4.000 | FALSE | FALSE |
------------------------------------------------------------------------
@@ -236,14 +236,14 @@ here](https://amr-for-r.org/reference/microorganisms.groups.html).
**Example content**
| mo_group | mo | mo_group_name | mo_name |
|:--------------:|:------------:|:-------------------------------:|:---------------------------:|
| B_ACNTB_BMNN-C | B_ACNTB_BMNN | Acinetobacter baumannii complex | Acinetobacter baumannii |
| mo_group | mo | mo_group_name | mo_name |
|:--:|:--:|:--:|:--:|
| B_ACNTB_BMNN-C | B_ACNTB_BMNN | Acinetobacter baumannii complex | Acinetobacter baumannii |
| B_ACNTB_BMNN-C | B_ACNTB_CLCC | Acinetobacter baumannii complex | Acinetobacter calcoaceticus |
| B_ACNTB_BMNN-C | B_ACNTB_LCTC | Acinetobacter baumannii complex | Acinetobacter dijkshoorniae |
| B_ACNTB_BMNN-C | B_ACNTB_NSCM | Acinetobacter baumannii complex | Acinetobacter nosocomialis |
| B_ACNTB_BMNN-C | B_ACNTB_PITT | Acinetobacter baumannii complex | Acinetobacter pittii |
| B_ACNTB_BMNN-C | B_ACNTB_SFRT | Acinetobacter baumannii complex | Acinetobacter seifertii |
| B_ACNTB_BMNN-C | B_ACNTB_NSCM | Acinetobacter baumannii complex | Acinetobacter nosocomialis |
| B_ACNTB_BMNN-C | B_ACNTB_PITT | Acinetobacter baumannii complex | Acinetobacter pittii |
| B_ACNTB_BMNN-C | B_ACNTB_SFRT | Acinetobacter baumannii complex | Acinetobacter seifertii |
------------------------------------------------------------------------
@@ -394,14 +394,14 @@ here](https://amr-for-r.org/reference/dosage.html).
**Example content**
| ab | name | type | dose | dose_times | administration | notes | original_txt | eucast_version |
|:---:|:-----------:|:-----------------:|:-----------:|:----------:|:--------------:|:-----:|:------------------:|:--------------:|
| AMK | Amikacin | standard_dosage | 25-30 mg/kg | 1 | iv | | 25-30 mg/kg x 1 iv | 15 |
| AMX | Amoxicillin | high_dosage | 2 g | 6 | iv | | 2 g x 6 iv | 15 |
| AMX | Amoxicillin | standard_dosage | 1 g | 3 | iv | | 1 g x 3-4 iv | 15 |
| AMX | Amoxicillin | high_dosage | 0.75-1 g | 3 | oral | | 0.75-1 g x 3 oral | 15 |
| AMX | Amoxicillin | standard_dosage | 0.5 g | 3 | oral | | 0.5 g x 3 oral | 15 |
| AMX | Amoxicillin | uncomplicated_uti | 0.5 g | 3 | oral | | 0.5 g x 3 oral | 15 |
| ab | name | type | dose | dose_times | administration | notes | original_txt | eucast_version |
|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|
| AMK | Amikacin | standard_dosage | 25-30 mg/kg | 1 | iv | | 25-30 mg/kg x 1 iv | 15 |
| AMX | Amoxicillin | high_dosage | 2 g | 6 | iv | | 2 g x 6 iv | 15 |
| AMX | Amoxicillin | standard_dosage | 1 g | 3 | iv | | 1 g x 3-4 iv | 15 |
| AMX | Amoxicillin | high_dosage | 0.75-1 g | 3 | oral | | 0.75-1 g x 3 oral | 15 |
| AMX | Amoxicillin | standard_dosage | 0.5 g | 3 | oral | | 0.5 g x 3 oral | 15 |
| AMX | Amoxicillin | uncomplicated_uti | 0.5 g | 3 | oral | | 0.5 g x 3 oral | 15 |
------------------------------------------------------------------------
@@ -424,14 +424,14 @@ here](https://amr-for-r.org/reference/example_isolates.html).
**Example content**
| date | patient | age | gender | ward | mo | PEN | OXA | FLC | AMX | AMC | AMP | TZP | CZO | FEP | CXM | FOX | CTX | CAZ | CRO | GEN | TOB | AMK | KAN | TMP | SXT | NIT | FOS | LNZ | CIP | MFX | VAN | TEC | TCY | TGC | DOX | ERY | CLI | AZM | IPM | MEM | MTR | CHL | COL | MUP | RIF |
|:----------:|:-------:|:---:|:------:|:--------:|:------------:|:---:|:---:|:---:|:---:|:---:|:---:|:---:|:---:|:---:|:---:|:---:|:---:|:---:|:---:|:---:|:---:|:---:|:---:|:---:|:---:|:---:|:---:|:---:|:---:|:---:|:---:|:---:|:---:|:---:|:---:|:---:|:---:|:---:|:---:|:---:|:---:|:---:|:---:|:---:|:---:|
| 2002-01-02 | A77334 | 65 | F | Clinical | B_ESCHR_COLI | R | | | | I | | | | | I | | | | | | | | | R | R | | | R | | | R | R | R | | | R | R | R | | | | | | | R |
| 2002-01-03 | A77334 | 65 | F | Clinical | B_ESCHR_COLI | R | | | | I | | | | | I | | | | | | | | | R | R | | | R | | | R | R | R | | | R | R | R | | | | | | | R |
| 2002-01-07 | 067927 | 45 | F | ICU | B_STPHY_EPDR | R | | R | | | | | | | R | | | R | | | | | | S | S | | | | | | S | | S | S | S | R | | R | | | | | R | | |
| 2002-01-07 | 067927 | 45 | F | ICU | B_STPHY_EPDR | R | | R | | | | | | | R | | | R | | | | | | S | S | | | | | | S | | S | S | S | R | | R | | | | | R | | |
| 2002-01-13 | 067927 | 45 | F | ICU | B_STPHY_EPDR | R | | R | | | | | | | R | | | R | | | | | | R | | | | | | | S | | S | S | S | R | | R | | | | | R | | |
| 2002-01-13 | 067927 | 45 | F | ICU | B_STPHY_EPDR | R | | R | | | | | | | R | | | R | | | | | | R | | | | | | | S | | S | S | S | R | R | R | | | | | R | | |
| date | patient | age | gender | ward | mo | PEN | OXA | FLC | AMX | AMC | AMP | TZP | CZO | FEP | CXM | FOX | CTX | CAZ | CRO | GEN | TOB | AMK | KAN | TMP | SXT | NIT | FOS | LNZ | CIP | MFX | VAN | TEC | TCY | TGC | DOX | ERY | CLI | AZM | IPM | MEM | MTR | CHL | COL | MUP | RIF |
|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|
| 2002-01-02 | A77334 | 65 | F | Clinical | B_ESCHR_COLI | R | | | | I | | | | | I | | | | | | | | | R | R | | | R | | | R | R | R | | | R | R | R | | | | | | | R |
| 2002-01-03 | A77334 | 65 | F | Clinical | B_ESCHR_COLI | R | | | | I | | | | | I | | | | | | | | | R | R | | | R | | | R | R | R | | | R | R | R | | | | | | | R |
| 2002-01-07 | 067927 | 45 | F | ICU | B_STPHY_EPDR | R | | R | | | | | | | R | | | R | | | | | | S | S | | | | | | S | | S | S | S | R | | R | | | | | R | | |
| 2002-01-07 | 067927 | 45 | F | ICU | B_STPHY_EPDR | R | | R | | | | | | | R | | | R | | | | | | S | S | | | | | | S | | S | S | S | R | | R | | | | | R | | |
| 2002-01-13 | 067927 | 45 | F | ICU | B_STPHY_EPDR | R | | R | | | | | | | R | | | R | | | | | | R | | | | | | | S | | S | S | S | R | | R | | | | | R | | |
| 2002-01-13 | 067927 | 45 | F | ICU | B_STPHY_EPDR | R | | R | | | | | | | R | | | R | | | | | | R | | | | | | | S | | S | S | S | R | R | R | | | | | R | | |
------------------------------------------------------------------------
@@ -555,11 +555,11 @@ contain the trade names and LOINC codes as comma separated values.
**Example content**
| av | name | atc | cid | atc_group | synonyms | oral_ddd | oral_units | iv_ddd | iv_units | loinc |
|:---:|:------------------:|:-------:|:---------:|:------------------------------------------------------------------:|:-----------------------------------------------------:|:--------:|:----------:|:------:|:--------:|:----------------------------:|
| ABA | Abacavir | J05AF06 | 441300 | Nucleoside and nucleotide reverse transcriptase inhibitors | abacavir sulfate, avacavir, ziagen | 0.6 | g | | | 29113-8, 30273-7, 30287-7, … |
| ACI | Aciclovir | J05AB01 | 135398513 | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | acicloftal, aciclovier, aciclovirum, … | 4.0 | g | 4 | g | |
| ADD | Adefovir dipivoxil | J05AF08 | 60871 | Nucleoside and nucleotide reverse transcriptase inhibitors | adefovir di, adefovir di ester, adefovir dipivoxyl, … | 10.0 | mg | | | |
| AME | Amenamevir | J05AX26 | 11397521 | Other antivirals | amenalief | 0.4 | g | | | |
| AMP | Amprenavir | J05AE05 | 65016 | Protease inhibitors | agenerase, carbamate, prozei | 1.2 | g | | | 29114-6, 30296-8, 30297-6, … |
| ASU | Asunaprevir | J05AP06 | 16076883 | Antivirals for treatment of HCV infections | sunvepra, sunvepratrade | 0.2 | g | | | |
| av | name | atc | cid | atc_group | synonyms | oral_ddd | oral_units | iv_ddd | iv_units | loinc |
|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|
| ABA | Abacavir | J05AF06 | 441300 | Nucleoside and nucleotide reverse transcriptase inhibitors | abacavir sulfate, avacavir, ziagen | 0.6 | g | | | 29113-8, 30273-7, 30287-7, … |
| ACI | Aciclovir | J05AB01 | 135398513 | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | acicloftal, aciclovier, aciclovirum, … | 4.0 | g | 4 | g | |
| ADD | Adefovir dipivoxil | J05AF08 | 60871 | Nucleoside and nucleotide reverse transcriptase inhibitors | adefovir di, adefovir di ester, adefovir dipivoxyl, … | 10.0 | mg | | | |
| AME | Amenamevir | J05AX26 | 11397521 | Other antivirals | amenalief | 0.4 | g | | | |
| AMP | Amprenavir | J05AE05 | 65016 | Protease inhibitors | agenerase, carbamate, prozei | 1.2 | g | | | 29114-6, 30296-8, 30297-6, … |
| ASU | Asunaprevir | J05AP06 | 16076883 | Antivirals for treatment of HCV infections | sunvepra, sunvepratrade | 0.2 | g | | | |